Form 8-K - Current report:
SEC Accession No. 0000950170-22-017988
Filing Date
2022-09-01
Accepted
2022-08-31 19:13:34
Documents
12
Period of Report
2022-08-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K me-20220825.htm   iXBRL 8-K 92320
  Complete submission text file 0000950170-22-017988.txt   215514

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT me-20220825.xsd EX-101.SCH 2465
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT me-20220825_pre.xml EX-101.PRE 11038
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT me-20220825_lab.xml EX-101.LAB 17713
6 EXTRACTED XBRL INSTANCE DOCUMENT me-20220825_htm.xml XML 4542
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39587 | Film No.: 221219180
SIC: 2834 Pharmaceutical Preparations